Question:
-The guideline addresses the information to be submitted in registration applications for new molecular entities and associated drug products.
Author: LEIGHTON DWIGHT OBILLOSAnswer:
Scope of the Guideline
0 / 5 Â (0 ratings)
1 answer(s) in total